Hepcidin—A Potential Novel Biomarker for Iron Status in Chronic Kidney Disease

AUTOR(ES)

Zaritsky, Joshua

FONTE

American Society of Nephrology

RESUMO

Background and objectives: Hepcidin is a key regulator of iron homeostasis, but its study in the setting of chronic kidney disease (CKD) has been hampered by the lack of validated serum assays.

Documentos Relacionados

• Cathepsin S as an early biomarker for cardiovascular disease in chronic kidney disease patients
• Soluble TWEAK Plasma Levels as a Novel Biomarker of Endothelial Function in Patients with Chronic Kidney Disease
• Novel treatment options for chronic kidney disease complications
• The effect of hepcidin on components of metabolic syndrome in chronic kidney disease: a cross-sectional study
• Hepcidin: A putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease